IP Library Granted Patent US 9,522,247
Granted Patent B2
US 9,522,247 · App. 13/930,435 · Granted Dec 20, 2016

Method of treating a patient having pulmonary hypertension by long term NO therapy

Inventor: Andrew Martin (Wilmington, DE)
Assignee: L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude
A61M16/0672A61M16/0666A61M16/122A61M16/208A61M16/0866A61M2202/0208A61M2202/0275
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,522,247
App. No.
13/930,435
Granted
Dec 20, 2016
Kind
B2
Abstract

The invention concerns a nasal cannula assembly ( 10 ) adapted to deliver gases to a patient comprising a first compartment ( 1 ) and a second compartment ( 2 ) separated by a separation wall ( 6 ); a pair of nasal prongs ( 5 ) in fluid communication with the first compartment ( 1 ); the first compartment ( 1 ) comprising a first inlet ( 11 ) for introducing a first gas into said first compartment ( 1 ); the second compartment ( 2 ) comprising a second inlet ( 2 ) for introducing a second gas into said second compartment ( 2 ); and the separation wall ( 6 ) comprising at least one valve element ( 3 ) for controlling the passage of gas from the second compartment ( 2 ) to the first compartment ( 1 ). The invention concerns also a breathing assistance apparatus comprising a source of NO gas, and said nasal cannula assembly ( 10 ) in fluid communication with said source of NO gas.

Claims (24)

1. A method for treating pulmonary vasoconstriction in a patient, comprising:

a) providing a nasal cannula assembly ( 10 ) adapted to deliver gases to the patient, the nasal cannula assembly ( 10 ) comprising:

A) a hollow body ( 4 ) configured to be capable of acting as a gas conduct or a gas manifold and comprising an internal chamber ( 7 ) defining a first compartment ( 1 ),

B) the first compartment ( 1 ) and a second compartment ( 2 ) separated by a separation wall ( 6 ),

C) a pair of nasal prongs ( 5 ) in fluid communication with the first compartment ( 1 ),

D) the first compartment ( 1 ) comprising a first inlet ( 11 ) forming a side gases entry in fluid communication with a gas transport conduct and configured to conduct a first gas into said first compartment ( 1 ),

E) the second compartment ( 2 ) having a fully inflated internal volume for a gas of about 0.5 to 5 ml, the second compartment ( 2 ) comprising,

a second inlet ( 12 ) configured to conduct a second gas into said second compartment ( 2 ), and

a deformable wall ( 14 ) having a greater compliance while filling than when the second compartment ( 2 ) is full,

F) the separation wall ( 6 ) comprising two, one-way, duckbill or umbrella valves ( 3 ) a cracking pressure of 0.5 kPa or less which are oriented and arranged in the separation wall ( 6 ) directly opposite the pair of nasal prongs ( 5 ) to thereby be capable of

permitting a passage of gas from the second compartment ( 2 ) to the first compartment ( 1 ) and

preventing or limiting a passage of gas from the first compartment ( 1 ) to the second compartment ( 2 ),

b) providing a source of NO-containing gas having from 1 ppm to 5000 ppm in volume of NO in a balance of nitrogen in fluid communication with the nasal cannula assembly ( 10 ),

c) providing a source of an oxygen-containing gas containing at least 21% (by volume) of O 2 in fluid communication with the nasal cannula assembly ( 10 ), and

d) providing a therapeutically-effective amount of the NO-containing gas to said patient through said nasal cannula assembly for inhalation.

2. The method according to claim 1 , wherein the patient is an adult, an infant or a newborn.

3. The method according to claim 1 , wherein the patient is a newborn and has pulmonary vasoconstriction associated with persistent pulmonary hypertension.

4. The method according to claim 1 , wherein the patient has pulmonary vasoconstriction associated with pulmonary arterial hypertension.

5. The method according to claim 1 , wherein the hollow body ( 4 ) and said pair of nasal prongs ( 5 ) are integrally molded from a soft plastics material.

6. The method according to claim 1 , wherein the pair of nasal prongs ( 5 ) are detachable from said hollow body ( 4 ) and selected from different sized prongs suitable for different sized patient nares.

7. The method according to claim 1 , wherein the nasal cannula assembly does not comprise a sensor configured to detect an onset of patient inspiration.

8. The method according to claim 1 , wherein the pair of nasal prongs ( 5 ) includes an external pillow element ( 8 ) at an end.

9. The method according to claim 8 , wherein the external pillow element ( 8 ) is made of silicone.

10. The method according to claim 1 , wherein the nasal cannula assembly further comprises an expiratory orifice ( 13 ) in the first compartment ( 1 ) defining a fluid communication path from an internal chamber ( 7 ) to an external atmosphere.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2014
From: AMERICAN AIR LIQUIDE, INC.
To: L'AIR LIQUIDE, SOCIÉTÉ ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCÉDÉS GEORGES CLAUDE
Reel/Frame 033454/0032 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2013
From: MARTIN, ANDREW
To: AMERICAN AIR LIQUIDE, INC.
Reel/Frame 030950/0091 →
Continuity (1)
Related Publication 20150000659A1 · Jan 1, 2015